ActinomycinD , 98% , 50-76-0
                            Synonym(s):
Dactinomycin;Actinomycin D;Actinomycin D solution from Streptomyces sp.;Actinomycin D, Streptomyces sp. - CAS 50-76-0 - Calbiochem;Actinomycin IV
                            
                        
                CAS NO.:50-76-0
Empirical Formula: C62H86N12O16
Molecular Weight: 1255.42
MDL number: MFCD00005033
EINECS: 200-063-6
PRODUCT Properties
| Melting point: | 251-253 °C | 
                                    
| Boiling point: | 848°C (rough estimate) | 
                                    
| Density | 1.0757 (rough estimate) | 
                                    
| refractive index | 1.5700 (estimate) | 
                                    
| Flash point: | 87℃ | 
                                    
| storage temp. | 2-8°C | 
                                    
| solubility | ethanol, DMSO: Stable in aqueous solutions at 2-8 °C.soluble | 
                                    
| form | powder | 
                                    
| pka | 8.94±0.70(Predicted) | 
                                    
| color | red, powder | 
                                    
| biological source | Streptomyces sp. | 
                                    
| optical activity | [α]/D alpha: 28/D (Rotation: -315 degrees (c=0.25% in methanol)) | 
                                    
| Water Solubility | SOLUBLE | 
                                    
| Merck | 13,2828 | 
                                    
| BRN | 605235 | 
                                    
| Stability: | Stable, but light sensitive, especially in dilute solution. Incompatible with strong acids, strong bases, strong oxidizing agents. Combustible. | 
                                    
| CAS DataBase Reference | 50-76-0(CAS DataBase Reference) | 
                                    
| IARC | 3 (Vol. 10, Sup 7) 1987 | 
                                    
| EPA Substance Registry System | Actinomycin D (50-76-0) | 
                                    
Description and Uses
Actinomycin D (50-76-0) is a cyclopeptide antibiotic and intercalating transcription inhibitor with anti-neoplastic activity. Potent inhibitor of RNA polymerase.1?Induces apoptosis in a variety of cancer cell lines2,3via the intrinsic pathway4.? Upregulates proapoptotic PUMA and downregulates Bcl-2 mRNA in peripheral blood lymphocytes.5
An antineoplastic antibiotic that inhibits cell proliferation by forming a stable complex with DNA and blocking the movement of RNA polymerase which interferes with DNA-dependent RNA synthesis. Induces apoptosis. Potent antitumor agent.
Safety
| Symbol(GHS) | ![]() ![]() GHS06,GHS08  | 
                                    
| Signal word | Danger | 
| Hazard statements | H300-H350-H360FD | 
| Precautionary statements | P201-P202-P264-P270-P280-P301+P310 | 
| Hazard Codes | T+ | 
| Risk Statements | 28-61-40-45-26/27/28 | 
| Safety Statements | 53-36/37/39-45-1-36/37-28-22 | 
| RIDADR | UN 3462 6.1/PG 2 | 
| WGK Germany | 3 | 
| RTECS | AU1575000 | 
| F | 8-10-21 | 
| HazardClass | 6.1(a) | 
| PackingGroup | II | 
| HS Code | 29419000 | 
| Hazardous Substances Data | 50-76-0(Hazardous Substances Data) | 
| Toxicity | LD50 oral in rat: 7200ug/kg | 






